VP Alliance management & Partnerships at Biocartis
Brussels Area, Belgium
Head of Research & Development @ Member of Biocartis' Executive management team. Head of Reseach & Development (Molecular diagnostics applications & technology) on Biocartis Idylla platform (a fully integrated qPCR molecular diagnostics platform) and Biocartis Polaris platform (a target enrichment platform). Full IVD assay development capabilities including exploratory research, feasibilities, early and late stage development under design...
Head of Research & Development @ Member of Biocartis' Executive management team. Head of Reseach & Development (Molecular diagnostics applications & technology) on Biocartis Idylla platform (a fully integrated qPCR molecular diagnostics platform) and Biocartis Polaris platform (a target enrichment platform). Full IVD assay development capabilities including exploratory research, feasibilities, early and late stage development under design control; management of support teams in the fields of method development, BioIT and assay software development. Managemant of internal and external assay development project portfolio with current focus on oncology (melanoma, colorectal cancer, lung cancer and others) and infectious disease applications (sepsis and virology applications). Alliance management of Biocartis' assay development partners. Member of the Joint Steering Committee of major research and development collaborations. From August 2012 to Present (3 years 5 months) Director Diagnostics Development & Alliance Management @ Set up and management of the IVD assay development department on Biocartis Idylla fully integrated qPCR molecular diagnostics platform. Full IVD development capabilities including feasibilities, early and late stage development under design control, including support teams in the fields of method development, industrialisation, BioIT and assay software development. Managing assay development projects on the Idylla platform in the fields of infectious diseases and oncology. Alliance management of Biocartis' consortium partners. Member of the Joint Steering Committee of major research and development collaborations. From June 2010 to August 2012 (2 years 3 months) Director Project Management @ Head of the project management department. Leading a team of dedicated project managers covering Ablynx internal nanobody development portfolio as well as external co-development projects with Pharma partners (Boehringer Ingelheim, Novartis, Wyeth, Merck Serono,...). Set up and management of the project management office. Co-chair of the portfolio management committee and member of the Operational Management committee. From October 2008 to June 2010 (1 year 9 months) Gent Area, BelgiumAssociate Director Project Management @ Management of internal and external projects in the field of alternative delivery systems for nanobodies From June 2008 to September 2008 (4 months) Head Infectious Diseases Dept., R&D @ Managing R&D teams active in the development of molecular diagnostics and immunodiagnostics in the field of infectious diseases with focus on HCV, HBV, HPV, HIV and microbiology applications. Responsibility from proof of concept untill product launch preparation in the fields of screening, diagnosis, genotyping and therapy monitoring (including drug resistance testing) From January 2005 to May 2008 (3 years 5 months) Head Virology Dept, R&D @ Managing R&D teams active in the development of molecular diagnostics in the field of virology with focus on HCV, HBV, HPV and HIV. Responsibility from proof of concept untill product launch preparation. From 1998 to 2005 (7 years) Head Microbiology & bioprocessing unit @ Managing an R&D team responsible for protein expression (bacterial and yeast expression systems), protein engineering (including antibody engineering and humanization), and bioprocessing (fermentation up to 100 l) support for diagnostic and therapeutic projects From 1996 to 1998 (2 years) Head Microbiology Unit @ Managing an R&D team responsible for protein expression (bacterial and yeast expression systems) and protein engineering support for diagnostic and therapeutic projects From January 1992 to 1996 (4 years) Scientist @ Molecular Biologist, Protein engineering and protein production expert From April 1990 to 1992 (2 years) Executive MBA, General Business administration, Great Distinction @ Vlerick Leuven-Gent Management School From 2007 to 2009 PhD, Molecular Biology @ Universiteit Gent From 1986 to 1990 Master, Biotechnology @ Ghent University From 1982 to 1986 Sint Donatus Instituut Merchtem From 1976 to 1982 Erwin Sablon is skilled in: Infectious Diseases, Protein Engineering, Diagnostics, Intellectual Property, Virology, Portfolio Management, PCR, Genetics, Oncology, People Management, Grant Management, Budget Management, R&D, Protein Expression, Microbiology
Biocartis
Head of Research & Development
August 2012 to Present
Biocartis
Director Diagnostics Development & Alliance Management
June 2010 to August 2012
Ablynx NV
Director Project Management
October 2008 to June 2010
Gent Area, Belgium
Ablynx NV
Associate Director Project Management
June 2008 to September 2008
Innogenetics
Head Infectious Diseases Dept., R&D
January 2005 to May 2008
Innogenetics NV
Head Virology Dept, R&D
1998 to 2005
Innogenetics NV
Head Microbiology & bioprocessing unit
1996 to 1998
Innogenetics
Head Microbiology Unit
January 1992 to 1996
Innogenetics
Scientist
April 1990 to 1992
Vlerick Leuven-Gent Management School
Executive MBA General Business administration Great Distinction
2007 to 2009
Universiteit Gent
PhD Molecular Biology
1986 to 1990
Ghent University
Master Biotechnology
1982 to 1986
Sint Donatus Instituut Merchtem
1976 to 1982
Member of Biocartis' Executive management team. Head of Reseach & Development (Molecular diagnostics applications & technology) on Biocartis Idylla platform (a fully integrated qPCR molecular diagnostics platform) and Biocartis Polaris platform (a target enrichment platform). Full IVD assay development capabilities including exploratory research, feasibilities, early and late stage development under design control; management of support teams in... Member of Biocartis' Executive management team. Head of Reseach & Development (Molecular diagnostics applications & technology) on Biocartis Idylla platform (a fully integrated qPCR molecular diagnostics platform) and Biocartis Polaris platform (a target enrichment platform). Full IVD assay development capabilities including exploratory research, feasibilities, early and late stage development under design control; management of support teams in the fields of method development, BioIT and assay software development. Managemant of internal and external assay development project portfolio with current focus on oncology (melanoma, colorectal cancer, lung cancer and others) and infectious disease applications (sepsis and virology applications). Alliance management of Biocartis' assay development partners. Member of the Joint Steering Committee of major research and development collaborations.
What company does Erwin Sablon work for?
Erwin Sablon works for Biocartis
What is Erwin Sablon's role at Biocartis?
Erwin Sablon is Head of Research & Development
What industry does Erwin Sablon work in?
Erwin Sablon works in the Medical Devices industry.
Enjoy unlimited access and discover candidates outside of LinkedIn
One billion email addresses and counting
Everything you need to engage with more prospects.
ContactOut is used by
76% of Fortune 500 companies
Erwin Sablon's Social Media Links
www.biocar... journalogy...